Replimune (REPL) Tax Provisions (2023 - 2026)
Replimune (REPL) reported Tax Provisions of -$289000.0 for Q1 2026, down 285.33% on a YoY basis from $155935.3 in Q1 2025, and up 3.67% sequentially from -$300000.0 in Q4 2025.
Replimune (REPL) Tax Provisions (2023 - 2026) Analysis & Trends
Replimune (REPL) has 4 years of Tax Provisions data on file, last reported at -$289000.0 in Q1 2026.
- For the quarter ending Q1 2026, Tax Provisions fell 285.33% year-over-year to -$289000.0; the trailing twelve-month figure through Mar 2026 stood at -$89000.0 (down 117.8% YoY), and the FY2026 full-year result was -$600000.0, down 220.0% from the prior year.
- Tax Provisions climbed to -$289000.0 in Q1 2026, from -$300000.0 in the prior quarter.
- In the past five years, Tax Provisions ranged from a high of $575000.0 in Q4 2024 to a low of -$300000.0 in Q4 2025.
- A 4-year average of $68777.8 and a median of -$65000.0 in 2024 frame the typical range for Tax Provisions.
- Across the five-year window, Tax Provisions grew 21.56% in 2024 and sank 285.33% in 2026, its largest moves.
- Tracing REPL's Tax Provisions over 4 years: stood at $473000.0 in 2023, then gained by 21.56% to $575000.0 in 2024, then slumped by 152.17% to -$300000.0 in 2025, then grew by 3.67% to -$289000.0 in 2026.
- Business Quant data shows REPL's Tax Provisions at -$289000.0 in Q1 2026, -$300000.0 in Q4 2025, and -$75000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 125,146.46 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 31.86 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 188,883.60 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 221.50 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 104.00 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 179.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Replimune | 970.73 Mn | 970.73 Mn | - | -289,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -289,000.00 |
| Dec 31, 2025 | -300,000.00 |
| Mar 31, 2025 | -75,000.00 |
| Dec 31, 2024 | 575,000.00 |
| Mar 31, 2024 | -65,000.00 |
| Dec 31, 2023 | 473,000.00 |
| Sep 30, 2023 | -201,000.00 |
| Jun 30, 2023 | 201,000.00 |
| Mar 31, 2023 | 300,000.00 |